Biolinq

Biolinq Incorporated is a San Diego, California medical device and digital health company founded in 2012 that develops intradermal biowearable sensors. Its lead product, Biolinq Shine, is an autonomous needle-free continuous glucose sensor built on an array of electrochemical microsensors that sit just below the surface of the skin, combined with an accelerometer and an ambient light sensor so a single wearable measures glucose alongside activity and sleep. The sensor carries an on-body LED color indicator for time-in-range and pairs with a companion mobile application for trends and insights. The FDA granted Biolinq Shine De Novo classification for adults with type 2 diabetes not on insulin therapy, with a planned US market launch. Biolinq publishes no public developer program, API documentation, or machine-readable API contract; its public web presence is a corporate marketing site.

Biolinq is profiled on the APIs.io network. Tagged areas include Company, Health, Digital Health, Medical Devices, and Wearables.

Biolinq’s developer surface includes engineering blog and 9 more developer resources.

🌐 Visit website 📡 Source on GitHub

8.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyHealthDigital HealthMedical DevicesWearablesBiosensorsContinuous Glucose MonitoringDiabetes

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 8.3/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.4 / 17

Commercial Clarity 1.8 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 1.9 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/biolinq: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Contact

Contact

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 4

The organization behind the API

Website

Website

Blog

Blog

Careers

Careers

LinkedIn

Other 3

Properties that don't map to a standard resource type

Technology

Technology

Team

Team

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: biolinq
name: Biolinq
description: Biolinq Incorporated is a San Diego, California medical device and digital health company founded in 2012 that
  develops intradermal biowearable sensors. Its lead product, Biolinq Shine, is an autonomous needle-free continuous glucose
  sensor built on an array of electrochemical microsensors that sit just below the surface of the skin, combined with an accelerometer
  and an ambient light sensor so a single wearable measures glucose alongside activity and sleep. The sensor carries an on-body
  LED color indicator for time-in-range and pairs with a companion mobile application for trends and insights. The FDA granted
  Biolinq Shine De Novo classification for adults with type 2 diabetes not on insulin therapy, with a planned US market launch.
  Biolinq publishes no public developer program, API documentation, or machine-readable API contract; its public web presence
  is a corporate marketing site.
url: https://raw.githubusercontent.com/api-evangelist/biolinq/refs/heads/main/apis.yml
image: https://cdn.prod.website-files.com/6310feecd52f6e2e081df17e/633c9a9b7cdf016ec08ae0d3_biolinq-logo-white%203.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- Health
- Digital Health
- Medical Devices
- Wearables
- Biosensors
- Continuous Glucose Monitoring
- Diabetes
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/biolinq-domain-security.yml
- type: Website
  url: https://www.biolinq.com/
- type: Blog
  url: https://www.biolinq.com/biolinq-news
- type: PrivacyPolicy
  url: https://cdn.prod.website-files.com/6310feecd52f6e2e081df17e/63767368eaae7f190195aea9_Biolinq-June-2022-Privacy-Policy.pdf
- type: Contact
  url: https://www.biolinq.com/biolinq-contact
- type: Technology
  url: https://www.biolinq.com/technology
- type: Careers
  url: https://www.biolinq.com/biolinq-careers
- type: Team
  url: https://www.biolinq.com/biolinq-team
- type: LinkedIn
  url: https://www.linkedin.com/company/biolinq/
- type: SecondaryMarket
  url: https://forgeglobal.com/biolinq_stock/
x-enrichment:
  date: '2026-08-07'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: no-developer-program
  detail: Biolinq ships the Shine biosensor and a companion consumer mobile app only — its entire public web presence is an
    11-page Webflow marketing site whose /support page reads "Intentionally left blank", and api/developer/docs/app.biolinq.com
    all fail to resolve in DNS.
  evidence:
  - url: https://www.biolinq.com/support
    status: 200
  - url: https://www.biolinq.com/openapi.json
    status: 404
  - url: https://www.biolinq.com/.well-known/agent-card.json
    status: 404
  - url: https://www.biolinq.com/llms.txt
    status: 404
  - url: https://api.biolinq.com/
    status: 0
  checked: '2026-08-07'